Point of Care Respiratory Pathogen Testing for Antibiotic Stewardship in Primary Care

About the trial

Sponsor

University of Pennsylvania

Tested

Clinician Survey (behavioral), Focus Group (behavioral), Biofire Spotfire Respiratory (R) panel (diagnostic_test), Patient Survey (behavioral)

Dates

Started 2025-02-01; completion 2028-01

Results posted

Not yet

The goal of this study is to understand the use of point of care (POC) testing devices in primary care offices to help clinicians diagnose and appropriately treat patients who have symptoms of upper respiratory infections (URIs). The study will use the BIOFIRE® SPOTFIRE® Respiratory (R) Panel testing device, which is FDA-cleared and CLIA-Waived. This panel can identify up to 15 different viruses and bacteria that can cause URIs. These POC devices will be installed in primary care clinics within the University of Pennsylvania Health System. Patients who come to the clinic with cold-like symptoms (runny nose, cough) will be offered the test. If the patient agrees to the test, their clinicia…

From ClinicalTrials.gov, last updated 2026-02-19. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Biomerieux Inc reported $332,662 in research payments for this study in 2025 (46 payments).

Products named: Biofire Spotfire Control Station, Biofire Spotfire Respiratory/sore Throat (r/st) PAnel

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.